Intel Shares Plunge. Is It Time to Buy the Dip?

Intel reported Q4 revenue of $13.7 billion, down 4% year-over-year (product revenue $12.9 billion, down 1%), with CCG at $8.2 billion (-7%) and DCAI at $4.7 billion (+9%); foundry revenue rose 4% to $4.5 billion but posted an operating loss of $2.5 billion in the quarter and $10.3 billion for the year. Margins deteriorated (gross margin down 310 bps to 36.1%; adjusted gross margins down 420 bps to 37.9%), and management guided Q1 revenue to $11.7–$12.7 billion (midpoint $12.2B) with breakeven adjusted EPS and ~34.5% adjusted gross margin, missing LSEG analyst sales and EPS expectations and citing supply constraints; the company is prioritizing AI-related DCAI demand and foundry investment (18A demand, 14A capex contingent on customer commitments) but faces ongoing yield and execution risk, prompting a cautious view for investors.

Analysis

Market structure: Intel's miss reallocates near-term winners toward pure-play AI accelerators (NVDA) and external foundries (TSM/0001.T) and equipment suppliers (ASML, LRCX) that can capture capex if Intel ramps 14A/18A, while Intel (INTC) and its in-house foundry partners remain losers given a $2.5B quarterly foundry op loss and gross margin compression of ~310–420 bps. Competitive dynamics favor TSMC/TSM and Nvidia-led software ecosystems because Intel must convert 18A interest into signed contracts (customer decisions H2 2026–early 2027) to restore pricing power.

Risk assessment: Near term (days–weeks) the dominant risks are sentiment-driven downside and rising IV; medium term (months) execution risks — persistent yield issues and supply constraints — could force higher capex or dilution and extend losses beyond the $10.3B FY foundry drag. Tail risks include catastrophic yield failure or major customer defections to TSMC (high-impact, <20% probability) and a successful turnaround via large design wins (low-probability upside catalyst).

Trade implications: Tactical trades before the next earnings / customer-announcement window (next 6–12 weeks) should express a view that execution, not valuation, is the key: short INTC via limited-risk put spreads sized 1–3% of portfolio; pair with 1–2% long NVDA to capture AI reallocation. Options: buy 3–6 month INTC put spreads targeting 25–35% downside (long ~30% OTM put, short ~50% OTM put) and buy NVDA 6-month call spreads (20/40% OTM) to offset financing.

Contrarian angles: Consensus understates timing optionality — if Intel locks customer commitments in H2 2026, upside could be rapid (30–80% re-rate) as market re-prices future foundry cashflows; conversely, the market may be underrating dilution risk if capex overshoots. A balanced approach (small asymmetric shorts with call protection or paired longs in NVDA/TSM) captures this skew while guarding against a rapid ‘show-me’ re-rating on customer announcements.

Key Decisions for Investors

• Establish a limited-risk short on INTC sized 2% of portfolio via a 3-month put spread: buy a put ~30% below current price and sell a put ~50% below current price (adjust strikes to market), target 25–35% downside, exit on either 15% profit or if company announces locked customer commitments for 14A/18A by end of H2 2026.
• Enter a pair trade: long NVDA (NVDA) equal-dollar to the INTC short (1–2% portfolio weight), holding 6–12 months to capture secular AI demand; consider financing with the INTC put spread premium to keep net cash outlay neutral.
• Allocate 1% to a directional call-spread on NVDA (6-month, 20/40% OTM) as convex upside exposure while avoiding naked long calls; take profits at +50% or on material broad AI adoption evidence (large cloud provider win announcements by H2 2026).
• Trim or avoid incremental exposure to capital-intensive foundry suppliers tied primarily to Intel’s internal turnaround (reduce direct INTC-supplier exposure by ~50%) until Intel proves yield improvement for 14A/18A or signs multi-year customer deals (threshold: public customer commitments covering >50% projected 14A capacity by Q4 2026).